News 2024-03-08
Join Our Founder and CEO @ DCAT Week
Join Our Founder and CEO @ DCAT Week
What:
DCAT Member Company Announcement Forum
When:
10:36-10:43AM, on Monday March 18, 2024
Where:
InterContinental Barclay, Grand Ballroom (2nd Floor)
Porton Pharma Solutions Ltd (hereinafter referred to as Porton or the Company) will participate in the DCAT Week which will be held in New York, from March 18-21, 2024.
As the premiere event in New York City for the Global Bio/Pharmaceutical Manufacturing Value Chain, DCAT Week garners annual industry attention. Porton has consistently participated in this esteemed gathering. At this year’s conference, our Chairman & CEO, Oliver Ju, is scheduled to speak at the DCAT Member Company Announcement Forum on the opening day. He will unveil our latest European and US facilities and capabilities, highlighting how these expansions streamline and enhance our ability to meet your unique development needs with greater ease.
Throughout DCAT Week, the Porton management team, our business development (BD) specialists, and our scientists are eager to connect with you in New York.
Schedule a meeting with us: Arsalan Khan
Others
More
News 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.
